320 related articles for article (PubMed ID: 12227323)
1. Current status of research and development of vaginal contraceptive rings as a fertility control method in the female.
Roy S; Mishell Dr
Res Front Fertil Regul; 1983 May; 2(4):1-10. PubMed ID: 12227323
[TBL] [Abstract][Full Text] [Related]
2. Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.
Elkik F; Basdevant A; Jackanicz TM; Guy-Grand B; Mercier-Bodard C; Conard J; Bardin CW; Corvol P
J Clin Endocrinol Metab; 1986 Jul; 63(1):29-35. PubMed ID: 3086360
[TBL] [Abstract][Full Text] [Related]
3. Vaginal rings for contraception: endocrine parameters.
Olsson SE
Adv Contracept Deliv Syst; 1992; 8(1-2):71-3. PubMed ID: 12285565
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
[TBL] [Abstract][Full Text] [Related]
5. The hormonal ring. A new contraceptive gains acceptance.
Hardy EE; Reyes Q; Gomez F; Portes-carrasco R; Faundes A
IDRC Rep; 1984 Jul; 13(2):11. PubMed ID: 12313242
[TBL] [Abstract][Full Text] [Related]
6. [Information on advances in sciences and technology. Advances in contraceptive technology].
Andrade AT
Bol Cent Biol Reprod; 1993; 12(1):51-2. PubMed ID: 12345521
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
8. The vaginal contraceptive pill.
Coutinho E
IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
[TBL] [Abstract][Full Text] [Related]
9. [Current status of contraceptive vaginal rings].
Elstein M; Jackson R; Hickling D; Assendorp R
Contracept Fertil Sex (Paris); 1992 Jan; 20(1):15-9. PubMed ID: 12343624
[TBL] [Abstract][Full Text] [Related]
10. Where next with long-acting steroids?
Potts DM; Siemens AJ
IPPF Med Bull; 1984 Jun; 18(3):2-3. PubMed ID: 12266285
[TBL] [Abstract][Full Text] [Related]
11. The hormonal ring: a new contraceptive gains acceptance.
Asian Pac Popul Programme News; 1984 Dec; 13(4):39-40. PubMed ID: 12313703
[TBL] [Abstract][Full Text] [Related]
12. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
13. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
14. The progestagen releasing vaginal ring.
Elstein M; Nuttall ID
J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S51-7. PubMed ID: 12268770
[TBL] [Abstract][Full Text] [Related]
15. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
16. [Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel].
Elkik F; Basdevant A; Corvol P
Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1737-9. PubMed ID: 3938250
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
18. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
19. NORPLANT contraceptive implants advancing.
Segal SJ
Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
[TBL] [Abstract][Full Text] [Related]
20. [Pros and cons of triphasic oral contraception].
Berdah J
Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]